Pioneering a Novel Cauterising Alum and Silver Nitrate (CAS) Approach for Infantile Perianal Fistulas: A Retrospective Cohort Study
Abstract
Background: Perianal fistulas in infants pose significant management challenges, often necessitating a difficult choice between prolonged conservative observation and invasive surgical interventions. These treatment options are typically associated with prolonged discomfort or complications, highlighting the need for a more efficient alternative to address current challenges.
Aim and Method: This retrospective cohort study involved infants under 18 months treated for perianal fistulas, either as complications of perianal abscesses or as primary perianal fistulation, at the only paediatric surgical unit in X country from 1st August 2019 to 31st July 2023. The Cauterising Alum and Silver Nitrate (CAS) treatment involved flushing the fistula with alum and silver nitrate solutions, administered at two-week intervals until discharge ceased.
Results: A total of 21 fistulas in 18 patients were treated using CAS. The majority of patients achieved cessation of discharge within one month (90%), with only one case of fistula recurrence requiring an additional application of CAS and two other cases of recurrent abscess treated conservatively with drainage and antibiotics, without further recurrence. Follow-up at a mean of 15.5 months after symptom resolution revealed no adverse effects, although 24% developed simple granulomas requiring topical management.
Conclusion: The CAS treatment approach offers a promising, minimally invasive alternative for managing perianal fistulas in infants, achieving rapid resolution and avoiding surgery. Despite a small sample size and single-centre scope, the consistent protocol provides valuable insights into this effective outpatient option for infant care
Downloads
References
Rosen N, Gibbs D, Soffer S, Hong A, Sher M, Peña A. The nonoperative management of fistula-in-ano. J Pediatr Surg. 2000;35(6):938-9. doi:10.1053/jpsu.2000.6931.
Watanabe Y, Todani T, Yamamoto S. Conservative management of fistula in ano in infants. Pediatr Surg Int. 1998;13:274-6. doi:10.1007/s003830050315.
Chang H, Ryu J, Oh J. Clinical characteristics and treatment of perianal abscess and fistula-in-ano in infants. J Pediatr Surg. 2010;45(9):1832-6. doi:10.1016/j.jpedsurg.2010.03.021.
Stokes R, Wanaguru D, Saadi A, Adams S. Management of perianal abscesses in infants without general anaesthesia: a systematic review of the literature. Pediatr Surg Int. 2020;36:1317-25. doi:10.1007/s00383-020-04728-7.
Puliński M, Hawryluk N, Choiński W. Analysis of treatment methods and outcomes for perianal abscess (PA) and fistula in ano (FIA) in infants. Nowa Med. 2020;27(2):33-9. doi:10.25121/nm.2020.27.2.33.
Avicenna. The canon of medicine. In: Goodman LE, translator. Oxford: Oxford University Press; 1999. Chapter 2, Medical substances. Original work published 1025.
Goel AK, Rao MS, Bhagwat AG, Vaidyanathan S, Goswami AK, Sen TK. Intravesical irrigation with alum for the control of massive bladder hemorrhage. J Urol. 1985;133(6):956-7. doi:10.1016/s0022-5347(17)49330-x.
Arrizabalaga M, Extramiana J, Parra JL, Ramos C, Díaz González R, Leiva O. Treatment of massive haematuria with aluminous salts. Br J Urol. 1987;60(3):223-6. doi:10.1111/j.1464-410x.1987.tb05487.x.
Ostroff EB, Chenault OW Jr. Alum irrigation for the control of massive bladder hemorrhage. J Urol. 1982;128(5):929-30. doi:10.1016/s0022-5347(17)53282-6.
Alzomor AK, Moharram AS, Al Absi NM. Formulation and evaluation of potash alum as deodorant lotion and after shaving astringent as cream and gel. Int Curr Pharm J. 2014;3(2):228-33. doi:10.3329/icpj.v3i2.17512.
Amadi LO. A review of antimicrobial properties of alum and sundry applications. Acta Sci Microbiol. 2020;3(6):55-63. doi:10.31080/asmi.2020.03.0553.
Politano A, Campbell K, Rosenberger L, Sawyer R. Use of silver in the prevention and treatment of infections: silver review. Surg Infect (Larchmt). 2013;14(1):8-20. doi:10.1089/sur.2011.097.
Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009;27(1):76-83. doi:10.1016/j.biotechadv.2008.09.002.
Green M, Tailor H, Keh S. Historical use of silver nitrate for the management of epistaxis – evidence-based practice? J Laryngol Otol. 2022;137:962-4. doi:10.1017/S0022215122002146.
Stratakos G, Zuccatosta L, Porfyridis I, et al. Silver nitrate through flexible bronchoscope in the treatment of bronchopleural fistulae. J Thorac Cardiovasc Surg. 2009;138(3):603-7. doi:10.1016/j.jtcvs.2008.10.054.
Boudaya M, Smadhi H, Zribi H, et al. Conservative management of postoperative bronchopleural fistulas. J Thorac Cardiovasc Surg. 2013;146(3):575-9. doi:10.1016/j.jtcvs.2013.04.023.
Attaallah W, Tuney D, Gulluoglu B, et al. Should we consider topical silver nitrate irrigation as a definitive nonsurgical treatment for perianal fistula? Dis Colon Rectum. 2014;57:882-7. doi:10.1097/DCR.0000000000000143.
Kaya S, Altuntas YE, Kement M, et al. Outcomes of silver nitrate use in perianal fistula: are perianal fistulas still a nightmare for surgeons? Ann Ital Chir. 2019;90:480-4. PMID:31617853.
Shafer AD, McGlone TP, Flanagan RA. Abnormal crypts of Morgagni: the cause of perianal abscess and fistula-in-ano. J Pediatr Surg. 1987;22(3):203-4.
Shikha A, Ahmed M, Wong ER, Eltaeb K, Wong J. Limited incision-and-drainage versus conservative management of perianal abscess in infants. Pediatr Surg Trop. 2025;2(2):96-101.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Anas Shikha, Mashal Ahmed, Zahraa Zaghloul, Khalid Eltaeb, Janice Wong
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
